CARDINAL HEALTH INC
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Nov 5, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Oct 16, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 19, 2026 | RBC Capital | initiate | — → Outperform | — | 55% |
| Aug 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 13, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Aug 13, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 12, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 12, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 12, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 12, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Aug 12, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 12, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 12, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jul 24, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 23, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 20, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jul 9, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 2, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 4, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| May 1, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 28, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Apr 8, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Feb 24, 2026 | Barclays | maintain | Overweight → Overweight | $258 | 53% |
| Feb 10, 2026 | JP Morgan | maintain | Neutral → Neutral | $243 | 55% |
| Feb 10, 2026 | Wells Fargo | maintain | Overweight → Overweight | $256 | 54% |
| Feb 6, 2026 | Mizuho | maintain | Outperform → Outperform | $235 | 52% |
| Jan 29, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $245 | 54% |
| Jan 15, 2026 | Wells Fargo | maintain | Overweight → Overweight | $237 | 54% |
| Jan 9, 2026 | Citigroup | upgrade | Neutral → Buy | $244 | 54% |
| Dec 9, 2025 | Barclays | initiate | — → Overweight | $243 | 53% |
| Nov 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $221 | 54% |
| Nov 4, 2025 | Mizuho | maintain | Outperform → Outperform | $210 | 52% |
| Nov 3, 2025 | TD Cowen | maintain | Buy → Buy | $225 | 54% |
| Oct 31, 2025 | Citigroup | maintain | Neutral → Neutral | $190 | 54% |
| Oct 31, 2025 | UBS | maintain | Buy → Buy | $220 | 54% |
| Oct 31, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $220 | 58% |
| Aug 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $185 | 54% |
| Aug 13, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $190 | 58% |
| Aug 13, 2025 | Baird | maintain | Outperform → Outperform | $203 | 55% |
| Aug 12, 2025 | Leerink Partners | maintain | Outperform → Outperform | $186 | 51% |
| Jul 16, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $190 | 54% |
| Jun 13, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $181 | 54% |
| Jun 13, 2025 | Citigroup | maintain | Neutral → Neutral | $170 | 54% |
| Jun 12, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $180 | 58% |
| Jun 10, 2025 | B of A Securities | maintain | Buy → Buy | $170 | 53% |
| Jun 3, 2025 | Wells Fargo | upgrade | Equal-Weight → Overweight | $179 | 54% |
| Jun 2, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $175 | 58% |
| May 5, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $166 | 54% |
No cross-platform signals in the last 90 days